Anti-NFASC Antibody (R1G06)

Catalog No.

RMB46201

Species reactivity

Human, Mouse, Rat

Host species

Rabbit

Isotype

IgG

Clonality

Monoclonal

Tested applications

WB: 1:500-1:1000

Target

Neurofascin, NFASC, KIAA0756

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

Q810U3

Applications

WB

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4, 0.05% BSA, 50% Glycerol, 0.05% Sodium azide.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 4 ℃ for frequent use. Store at -20 ℃ for twelve months from the date of receipt.

Clone ID

R1G06

Anti-neurofascin-186 associated combined central and peripheral demyelination (CCPD): A novel entity., PMID:40157142

[Pan-neurofascin autoimmune nodopathy - an emerging and treatable differential diagnosis to Guillain-Barré syndrome]., PMID:40135266

Epitope Mapping of Anti-Neurofascin 155 Antibody in a Large Cohort of Autoimmune Nodopathy Patients., PMID:40129269

Super-resolution of nodal and paranodal disruption in anti-pan-neurofascin-associated autoimmune nodopathy., PMID:40051618

Pan-neurofascin autoimmune nodoparanodopathy: A case report and literature review., PMID:39854764

Clinical Manifestations and Treatment Responses in Pediatric Neurofascin 155-IgG4 Autoimmune Nodopathy., PMID:39823553

Different Patterns of Autoantibody Secretion by Peripheral Blood Mononuclear Cells in Autoimmune Nodopathies., PMID:39173087

[Clinical features of anti-neurofascin-155 antibody positive autoimmune nodopathy in 6 children]., PMID:39039882

Anti-neurofascin-155 antibody mediated a distinct phenotype of chronic inflammatory demyelinating polyradiculoneuropathy., PMID:38771386

Clinical characteristics of patients with autoimmune nodopathy with anti-neurofascin155 antibodies., PMID:38726012

Large-scale phenotyping of patients with long COVID post-hospitalization reveals mechanistic subtypes of disease., PMID:38589621

Anti-pan-neurofascin antibodies induce subclass-related complement activation and nodo-paranodal damage., PMID:36346134

Clinical and Laboratory Features in Anti-NF155 Autoimmune Nodopathy., PMID:34728497

A case with Neurofascin-155 IgG antibody-associated combined central and peripheral demyelination: Successfully treated with anti-CD20 monoclonal antibody., PMID:34624826

The prevalence of anti-neurofascin-155 antibodies in patients with neuromyelitis optica spectrum disorders., PMID:33998675

Neurofascin antibodies in chronic inflammatory demyelinating polyradiculoneuropathy: from intrinsic genetic background to clinical manifestations., PMID:33782779

Endogenously expressed Ranbp2 is not at the axon initial segment., PMID:33536249

Myelination defects in the medial prefrontal cortex of Fkbp5 knockout mice., PMID:33410216

Anti-pan-neurofascin IgM in COVID-19-related Guillain-Barré syndrome: Evidence for a nodo-paranodopathy., PMID:33190687

Optic, trigeminal, and facial neuropathy related to anti-neurofascin 155 antibody., PMID:33080117

[A case of neurofascin-155 antibody-positive chronic inflammatory demyelinating polyradiculoneuropathy successfully treated with Cyclosporine A]., PMID:32641627

Efficacy of low dose rituximab in treatment-resistant CIDP with antibodies against NF-155., PMID:32563125

Longitudinal study on nerve ultrasound and corneal confocal microscopy in NF155 paranodopathy., PMID:32432402

Motor neuropathy with conduction block due to pan-neurofascin antibodies in a patient with chronic lymphocytic leukemia., PMID:32129901

Antibodies against nodo-paranodal proteins are not present in genetic neuropathies., PMID:32102977

Electrophysiological features of chronic inflammatory demyelinating polyradiculoneuropathy associated with IgG4 antibodies targeting neurofascin 155 or contactin 1 glycoproteins., PMID:32078921

Unique HLA haplotype associations in IgG4 anti-neurofascin 155 antibody-positive chronic inflammatory demyelinating polyneuropathy., PMID:31864140

Antibodies to neurofascin, contactin-1, and contactin-associated protein 1 in CIDP: Clinical relevance of IgG isotype., PMID:31753915

Intrathecal cytokine profile in neuropathy with anti-neurofascin 155 antibody., PMID:31657126

Anti-pan-neurofascin IgG3 as a marker of fulminant autoimmune neuropathy., PMID:31454780

Acute-onset chronic inflammatory demyelinating polyneuropathy with anti-neurofascin-155 antibodies and bilateral facial nerve enhancement., PMID:31450157

Neurofascin-140 and -155 antibodies in an atypical case of poems syndrome., PMID:31018253

Anti-Neurofascin-155 IgG4 antibodies prevent paranodal complex formation in vivo., PMID:30869655

Tongue tremor in neurofascin-155 IgG4 seropositive chronic inflammatory polyradiculoneuropathy., PMID:30713112

Anti-neurofascin-155 antibody-positive neuromyelitis optica spectrum disorders., PMID:30665067

Tremor Associated with Chronic Inflammatory Demyelinating Polyneuropathy and Anti-Neurofascin-155 Antibodies., PMID:30619643

Anti-neurofascin autoantibody and demyelination., PMID:30582947

Presence of both anti-contactin 1 and anti-neurofascin 140 antibodies in a case of chronic inflammatory demyelinating polyneuropathy., PMID:30547099

Association of neurofascin IgG4 and atypical chronic inflammatory demyelinating polyneuropathy: A systematic review and meta-analysis., PMID:30240176

Neurofascin-155 IgM autoantibodies in patients with inflammatory neuropathies., PMID:29945879

Autoantibodies Against the Node of Ranvier in Seropositive Chronic Inflammatory Demyelinating Polyneuropathy: Diagnostic, Pathogenic, and Therapeutic Relevance., PMID:29867996

Subacute nodopathy with conduction blocks and anti-neurofascin 140/186 antibodies: an ultrastructural study., PMID:29800077

[Autoantibodies in Chronic Inflammatory Demyelinating Polyneuropathy]., PMID:29632287

Parallel fluctuation of anti-neurofascin 155 antibody levels with clinico-electrophysiological findings in patients with chronic inflammatory demyelinating polyradiculoneuropathy., PMID:29249367

[Efficacy of high-dose steroid pulse therapy for anti-galactocerebroside antibody-positive combined central and peripheral demyelination]., PMID:29187683

Neurofascin antibodies in autoimmune, genetic, and idiopathic neuropathies., PMID:29187518

Anti-NF155 chronic inflammatory demyelinating polyradiculoneuropathy strongly associates to HLA-DRB15., PMID:29145880

Neurofascin-155 IGG4 Neuropathy: Pathophysiological Insights, Spectrum of Clinical Severity and Response To treatment., PMID:29130507

ELectron microscopic abnormality and therapeutic efficacy in chronic inflammatory demyelinating polyneuropathy with anti-neurofascin155 immunoglobulin G4 antibody., PMID:28796305

Autoantibodies in chronic inflammatory neuropathies: diagnostic and therapeutic implications., PMID:28708133

Document Download

Anti-NFASC Antibody (R1G06).pdf